The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Johnson Set For Brexit Talks With French President

Thu, 22nd Aug 2019 07:50

(Alliance News) - UK Prime Minister Boris Johnson on Thursday is set for showdown Brexit talks in Paris, hours after French President Emmanuel Macron ruled out making concessions.

The UK government was buoyed on Wednesday after comments by German Chancellor Angela Merkel which seemed to indicate that European leaders could be willing to renegotiate the Withdrawal Agreement in a bid to avoid a no-deal Brexit.

Hosting Johnson at the Chancellery in Berlin, Merkel set Britain a 30-day deadline for coming up with an alternative solution to replace the Irish backstop – a bid to avoid a hard border in Northern Ireland after the UK's exit from the EU by keeping Britain aligned with certain regulations set by Brussels.

But Macron told reporters on Wednesday that the demands to renegotiate the Brexit deal were "not an option".

He said: "We have to help the British deal with this internal democratic crisis but we mustn't be hostage to it nor export it."

The frank comments could make Johnson's trip to the Elysee Palace a dicey affair, with the Conservative Party leader set to meet his French counterpart for lunch on Thursday at his official residence to discuss changing the terms of Britain's exit.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called down 0.4% at 7,177.90

----------

Hang Seng: down 0.9% at 26,032.40

Nikkei 225: closed up 0.1% at 20,628.01

DJIA: closed up 0.9% at 26,202.73

S&P 500: closed up 0.8% at 2,924.43

----------

GBP: down at USD1.2113 (USD1.2131)

EUR: down at USD1.1076 (USD1.1097)

Gold: down at USD1,501.56 per ounce (USD1,503.01)

Oil (Brent): firm at USD60.14 a barrel (USD60.75)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Thursday's Key Economic Events still to come

US Fed's Jackson Hole economic policy symposium opens

1100 BST UK CBI Distributive Trades Survey

1100 BST Ireland WPI

0830 CEST Switzerland Industrial Production

0845 CEST France New home sales

0915 CEST France Flash PMI

0930 CEST Germany Flash PMI

1000 CEST Eurozone Flash PMI

1330 CEST ECB accounts from last monetary policy meeting

1600 CEST EU FCCI Flash Consumer Confidence Indicator

0830 EDT Canada Wholesale trade

0830 EDT Canada Employment Insurance

0830 EDT US Unemployment Insurance Weekly Claims Report - Initial Claims

0945 EDT US US Flash Manufacturing PMI

0945 EDT US US Flash Services PMI

1030 EDT US EIA Weekly Natural Gas Storage Report

----------

US Federal Reserve will remain flexible and interest rates will not be on a "preset course" despite persistent risks from trade uncertainty and weak global growth, the central bank said Wednesday. Although the minutes of the Fed's policy meeting late last month showed officials were primarily focused on the risks to the US economy, amid fears about the blowback from President Donald Trump's trade war with Beijing, they stressed that they would keep their options open on their next steps. While they made no mention of Trump's constant attacks on Fed Chairman Jerome Powell, officials said they would be "guided by incoming information and its implications for the economic outlook" and avoid "any appearance of following a preset course," according to the minutes of the Fed's July 30-31 policy meeting. The July rate cut was viewed as "part of a recalibration... or mid-cycle adjustment" and, given the uncertainty surrounding the outlook, the officials "highlighted the need for policymakers to remain flexible and focused on the implications of incoming data for the outlook." However, the minutes showed the central bankers are not unified, with several opposed to cutting rates while a couple favored a bigger cut.

----------

A hard border on the island of Ireland would make a US-UK trade deal "highly unlikely", the UK prime minister has been warned. The Congressional Friends of Ireland, a group in the US Congress which supports and promotes peace and reconciliation in Northern Ireland, has written to Boris Johnson warning that it will oppose any US-UK trade deal if it risks undermining the Good Friday Agreement. According to the letter: "The US, and the more than 33 million Americans with Irish ancestry, share a genuine interest in the continued success of the Good Friday Agreement and the hard-won peace and prosperity it has brought to so many. That is why we strongly oppose any unravelling of the historic treaty or a return of a physical border on the island of Ireland under any circumstances. "We will oppose any US-UK trade deal if the Good Friday Agreement is undermined."

----------

US trade policies, including the trade war with China, will shrink US economic output by 0.3 percentage points by 2020, the US Congressional Budget Office said Wednesday. The report by the non-partisan government agency contradicts President Donald Trump's claims that the tariffs imposed on Chinese goods and Chinese retaliatory tariffs are not harming the US economy. "Tariffs reduce domestic GDP mostly by raising domestic prices, thereby reducing the purchasing power of consumers and increasing the cost of business investment," CBO Director Phillip Swagel said in a statement. US GDP growth is projected to slow from 2.5% in 2018 to 2.3% in 2019. Earlier this month, Trump unexpectedly postponed additional punitive tariffs on Chinese imports to December, anticipating adverse effects on consumer shopping ahead of the Christmas holiday.

----------

BROKER RATING CHANGES

----------

LIBERUM CUTS ANGLO AMERICAN TO 'SELL' ('HOLD') - TARGET 1500 (2200) PENCE

LIBERUM CUTS RIO TINTO TO 'SELL' ('HOLD') - TARGET 3300 (4500) PENCE

LIBERUM CUTS BHP GROUP TO 'SELL' ('HOLD') - TARGET 1400 (2000) PENCE

----------

COMPANIES - FTSE 100

----------

Building materials firm CRH reported interim profit growth and expanded its share buyback programme. Revenue for the first half of 2019 came in at EUR13.22 billion, up from EUR11.94 billion a year ago. Pretax profit rose to EUR707 million from EUR497 million. "On the back of our strategic initiatives, CRH has delivered significant profit growth in the first half of 2019, with a good performance in our heritage business and strong contributions from recent acquisitions," said Chief Executive Albert Manifold. He added: "We are pleased to report that the board plans to continue our share buyback programme with a further tranche of EUR350 million to be completed by year end. This will bring our total share repurchases in 2019 to EUR900 million."

----------

AstraZeneca said roxadustat has been approved in China for the treatment of anaemia in non-dialysis-dependent patients with chronic kidney disease. AstraZeneca and FibroGen China are collaborating on the development and commercialisation of roxadustat in China. FibroGen China, based in Beijing, is a wholly-owned subsidiary of FibroGen Inc.

----------

UAE-focused private healthcare firm NMC Health backed its annual guidance after a solid first half. Revenue for the first half of 2019 rose to USD1.24 billion from USD932.0 million, with pretax profit rising to USD140.6 million from USD118.7 million. NMC said it continues to view the future "with confidence" and reiterated its annual guidance. Separately, the company also said it intends to launch a USD200 million share buyback programme.

----------

COMPANIES - FTSE 250

----------

Animal genetics firm Genus said Finance Director Stephen Wilson has been promoted to the role of chief executive, with effect from "the close of business" on September 13. Current CEO Karim Bitar in March said he would be stepping down to head up ConvaTec. Wilson's finance responsibilities will be undertaken by Janet Duane, currently financial controller on an interim basis. A search for a permanent replacement finance director has already commenced.

----------

Gaming firm Playtech set out share buyback plans despite posting a fall in profit. Revenue for the six months to June 30 was EUR736.1 million, versus just EUR436.5 million a year ago. Pretax profit, however, fell to EUR28.0 million from EUR124.2 million after the firm booked EUR108.6 million in depreciation and amortisation charges, versus just EUR60.6 million a year ago. In addition, Playtech recognised a EUR87.4 million fair value gain on equity investments in the year ago period, which fell to just EUR141,000 in the first half of 2019. Playtech halved its interim dividend to 6.1 euro cents from 12.1 cents a year ago but, including a planned EUR25 million buyback, total shareholder returns were up 15% year-on-year for the half.

----------

COMPANIES - OTHER MAIN MARKET AND AIM

----------

Ryanair has lost a High Court bid to block strike action by its UK pilots – hours after winning a similar legal move in Dublin. A judge sitting in London on Wednesday rejected an urgent application by the airline for an injunction against the British Airline Pilots' Association. The decision by Justice Lambert came after Ryanair succeeded at the High Court in Dublin earlier on Wednesday in its bid to prevent pilots based in Ireland from going on a 48-hour strike from midnight on Thursday. The airline sought an urgent injunction from the judge in London just hours before the start of threatened industrial action by members of Balpa in a dispute over pay and conditions. After hearing submissions from Ryanair and Balpa, the judge dismissed the various grounds raised by the airline. Strike action by UK Ryanair pilots is due to take place on Thursday and Friday, with a second round of dates in September.

----------

Thursday's Shareholder Meetings

D4T4 Solutions

Castings

----------

London Briefing is available to subscribers as an email newsletter. Contact info@alliancenews.com

More News
Today 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
Today 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
Today 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
Today 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.